Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.

Reproductive sciences (Thousand Oaks, Calif.) - 1 Jan 2018

Turan Volkan, Bedoschi Giuliano, Emirdar Volkan, Moy Fred, Oktay Kutluk

Abstract excerpt

BACKGROUND: Aromatase inhibitors (AI) have been introduced to reduce estrogen exposure in women with estrogen-sensitive cancer undergoing ovarian stimulation for oocyte/embryo cryopreservation. There have been questions regarding whether the addition of AI and the presence of BRCA mutations affect cycle outcomes. We sought to determine the impact of letrozole and BRCA mutations on fertility preservation (FP)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aromatase Inhibitors
Share to Cryopreservation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fertilization in Vitro

Share to Follicle Stimulating Hormone

Share to Nitriles

Share to Oocytes

Share to Ovulation Induction

Share to Triazoles

Source

Identifiers

PMID: 28874104
DOI: 10.1177/1933719117728800

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.PMID 28874104Read ↗

Controlled Ovarian Stimulation Outcomes Across Different Malignancies in Women Undergoing Fertility Preservation: The Role of AMH and AFC in Predicting Ovarian ResponseSemantic proximity Read ↗

Fertility Preservation and Pregnancy in Women With and Without BRCA Mutation–Positive Breast CancerSemantic proximity Read ↗

Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An OverviewSemantic proximity Read ↗

Preserving Oocytes in OncofertilitySemantic proximity Read ↗

Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation.Semantic proximity Read ↗

Letrozole for Female InfertilitySemantic proximity Read ↗

Fertility preservation in breast cancer patients.Semantic proximity Read ↗

BRCA, infertility, and fertility preservation: a review for counseling.Semantic proximity Read ↗

Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases—an analysis of 992 stimulationsSemantic proximity Read ↗

Fertility preservation in patients with BRCA mutations or Lynch syndrome.Semantic proximity Read ↗

Specific Protocols of Controlled Ovarian Stimulation for Oocyte Cryopreservation in Breast Cancer PatientsSemantic proximity Read ↗

Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in BRCA-Pathogenic-Variant-Positive Breast Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.